Summary
CVS Health Corp's (CVS) 10-Q filing for the quarter ending September 29, 2017, indicates a solid performance with continued revenue growth driven by its Pharmacy Services and Retail Pharmacy segments. The company demonstrated an increase in both net revenues and operating income for the nine-month period compared to the prior year, reflecting strong operational execution and strategic initiatives. While facing a dynamic healthcare landscape, CVS Health maintained a healthy balance sheet and generated substantial operating cash flow, underscoring its financial stability and ability to fund ongoing operations and investments.
Financial Highlights
54 data pointsBeta
Financial Statements
Beta
| Revenue | $46.19B |
| Cost of Revenue | $39.05B |
| Gross Profit | $7.12B |
| Operating Expenses | $4.62B |
| Operating Income | $2.50B |
| Net Income | $1.28B |
| EPS (Basic) | $1.26 |
| EPS (Diluted) | $1.26 |
| Shares Outstanding (Basic) | 1.02B |
| Shares Outstanding (Diluted) | 1.02B |
Key Highlights
- 1Total net revenues increased for the nine months ended September 30, 2017, compared to the same period in 2016, driven by growth in Pharmacy Services and Retail Pharmacy.
- 2Operating income also showed an increase for the nine-month period, indicating improved profitability and operational efficiency.
- 3The company generated significant cash flow from operations during the first nine months of 2017, providing ample liquidity.
- 4The Retail Pharmacy segment benefited from same store sales growth, a key indicator of consumer demand and loyalty.
- 5Pharmacy Services segment performance was bolstered by an increasing number of total prescriptions filled.
- 6The balance sheet remained robust, with sufficient assets to cover liabilities, reflecting sound financial management.
- 7The filing details various legal proceedings, which are common for large corporations but should be monitored for potential material impact.